SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia

Status Active, not recruiting

Clinical Trial Summary

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of or treat early cancer. SGN-00101 may be effective in preventing the development of cervical cancer in patients with cervical intraepithelial neoplasia.

PURPOSE: This randomized phase II trial is studying how well SGN-00101 works in preventing cervical cancer in patients with cervical intraepithelial neoplasia and human papillomavirus.

Clinical Trial Description

OBJECTIVES:

- Compare the efficacy of SGN-00101 vs placebo in patients with grade II or III cervical intraepithelial neoplasia.

- Correlate clinical response, as defined by histologic demonstration of lesion regression, with potential surrogate markers of vaccine efficacy (e.g., spectroscopic changes in the epithelium, development of human papilloma virus (HPV)-specific mucosal and systemic T-cell responses, and levels of HPV-specific antibody in cervical secretions), in patients treated with this drug.

OUTLINE: This is a randomized, double-blind study. Patients are randomized to 1 of 2 treatment arms.

- Arm I: Patients receive SGN-00101 subcutaneously (SC) once a month for 3 consecutive months in the absence of disease progression or unacceptable toxicity.

- Arm II: Patients receive placebo SC as in arm I. Patients are followed monthly for 3 months after the last injection and then undergo large loop excision of the transformation zone under colposcopy at the fourth month. Patients with disease progression undergo immediate large loop excision.

PROJECTED ACCRUAL: A maximum of 80 patients (40 per treatment arm) will be accrued for this study. ;

Study Design

Allocation: Randomized, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00060099
Study type	Interventional
Source	National Cancer Institute (NCI)
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	May 2003

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01946217` - Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials	N/A
Completed	`NCT00550589` - Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus	Phase 2
Completed	`NCT00653146` - The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia	N/A
Terminated	`NCT00629577` - Gene Expression Profiling of Cervical Cancer Progression in Biopsies and Tissue Samples	Phase 1
Completed	`NCT00103246` - Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides	Phase 1
Completed	`NCT00066430` - Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia	Phase 1
Completed	`NCT00522197` - ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia	Phase 2
Completed	`NCT00003384` - Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer	N/A
Terminated	`NCT02574442` - Pilot Study In Vivo Confocal Microscopy Probe for Cervical Precancer
Completed	`NCT00719563` - American Ginseng in Treating Patients With Fatigue Caused by Cancer	Phase 3
Terminated	`NCT00899951` - Studying Fentanyl in Patients With Cancer	N/A
Terminated	`NCT00611650` - Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia	Phase 2
Completed	`NCT00873288` - Activating Collaborative CIS Support Via Targeted Provider Mailing	N/A
Completed	`NCT00462813` - Diindolylmethane in Treating Patients With Abnormal Cervical Cells	Phase 3
Completed	`NCT00006348` - Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment	Phase 3
Completed	`NCT00666731` - Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
Recruiting	`NCT04445532` - Hepatobiliary Tumors Tissue Samples Acquisition
Completed	`NCT00685568` - Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis	Phase 1
Terminated	`NCT00942422` - Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma	Phase 2
Completed	`NCT00788164` - Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia	Phase 1